---
figid: PMC10239578__12905_2023_2420_Fig5_HTML
pmcid: PMC10239578
image_filename: 12905_2023_2420_Fig5_HTML.jpg
figure_link: /pmc/articles/PMC10239578/figure/Fig4/
number: Fig. 4
figure_title: ''
caption: 'Postulated mechanisms involved in platinum-resistant OCCC. Red box/circle:
  significantly upregulated gene; blue box, significantly downregulated gene; gray
  box/circle: not significantly expressed gene or not included in this panel. GF,
  growth factor; FGF, fibroblast growth factor; NGF, nerve growth factor; EFNA5, ephrin-A5;
  ECM, extracellular matrix; RELN, reelin; RTK, receptor tyrosine kinase; PDGFRA,
  platelet-derived growth factor receptor, alpha polypeptide; ITGB8, integrin, beta
  8; ITGA8, integrin, alpha 8; GRB2, growth factor receptor-bound protein-2; GSK3,
  glycogen synthase kinase-3; CCND1, cyclin D1; CCDN3, cyclin D3'
article_title: Differential molecular pathway expression according to chemotherapeutic
  response in ovarian clear cell carcinoma.
citation: Min Yin, et al. BMC Womens Health. 2023;23:298.
year: '2023'

doi: 10.1186/s12905-023-02420-1
journal_title: BMC Women's Health
journal_nlm_ta: BMC Womens Health
publisher_name: BioMed Central

keywords:
- Ovarian clear cell carcinoma
- Gene expression profiling
- Drug resistance
- Platinum

---
